Non-Executive Directors – NHS Blood and Transplant (VAC-1678)Closed
|Body:||NHS Blood and Transplant|
|Appointing Department:||Department of Health|
|Number of Vacancies:||3|
|Remuneration:||NHSBT NEDs are remunerated at the standard rate of £7,883 per annum|
|Time Requirements:||Two to three days per month.|
Closed for Applications
17/12/2019 at 12:00
Final Interview Date
24/25 February 2020
Mark Davies Added 28/10/2019
DHSC Director of Population Health • Departmental Official
Political Activity None Declared Notes -
Millie Banerjee CBE Added 28/10/2019
Chair of NHS Blood and Transplant • Representative of Organisation
Political Activity None Declared Notes -
Moira Rankin Added 28/10/2019
Independent panel member • Independent Member
Political Activity Non Notes -
Ministers are seeking to make three appointments to the board of NHS Blood and Transplant.
Role and Responsibilities of a Non-Executive Director
As a Non-Executive Director, you will work with the Chair (Millie Banerjee); other non-executives; and the Chief Executive and her Executive team to govern the activities of NHSBT. With them you will share the corporate responsibility for the decisions of the Board and the performance of the organisation. You will:
- contribute to the development of strategy, agreeing the goals, business plans and objectives of the organisation taking into account the policies of the various UK health departments as necessary
- monitor and review performance ensuring that financial controls and systems of risk management are robust and effective
- help shape a positive and powerful culture in NHSBT through engaging with and providing ideas and guidance to the NHSBT team
- demonstrate a commitment to patient safety and to patients and staff being able to properly raise concerns
- represent the Board, as required, at official occasions and visits to NHSBT sites.
To be considered, you must be able to demonstrate that you have the qualities, skills and experience to meet all the essential criteria for appointment.
- ability to operate effectively on the board of a large and complex national organisation, contributing to challenging debate and working with others to reach decisions based on evidence and consensus
- ability to develop and deliver robust governance arrangements, including performance, financial and risk management
- an understanding of the broad role of NHSBT with an ability to articulate some of its key challenges
- experience of supporting effective delivery of substantial transformation in a private or public sector organisation
- have a significant career record of achievement and be able to demonstrate how your skills and experience can be used to the benefit of NHSBT, in one or more of the following areas:
- a clinician, working in the field of organ donation and transplantation
- an experienced scientist, who can bring relevant expertise in science/ science research to support the development of NHSBT and its services
- a strong track record in communications, marketing and working collaboratively with others to deliver successful outcomes in addition to the Essential Criteria, experience in organisational development and people/HR would be beneficial for one of the appointments.
2019/20 Board meeting dates:
- Thursday, 28 November 2019
- Thursday, 30 January 2020
- Thursday, 26 March 2020
- Thursday, 28 May 2020
- Thursday, 23 July 2020
- Thursday, 24 September 2020
- Thursday, 26 November 2020
Letter from Millie Banerjee, Chair
Thank you for your interest in the role of Non-Executive Director for NHS Blood and Transplant. At NHSBT we stand for hope. We stand for life. We stand for helping people do something extraordinary, saving and improving the lives of others. As an essential part of the NHS we take pride in playing our part to make the most of absolutely every donation – from blood and organs to tissues and stem cells. Every day we bring our values of caring, expert and quality to our roles. When we break new scientific ground, when we connect with donors and families, when we help to save a life – it’s because of each and every one of us. The donors who make our work possible do so selflessly, giving life and changing lives for the better. It is because of them, and the people who need their life-saving and life-enhancing donations, that we strive to be the best in all we do.
You will be joining us at an exciting and challenging time. Our Chief Executive, Betsy Bassis, joined us in March 2019 and she is currently leading a review of our Operating Model ensuring that we are set for future success. This builds on NHSBT’s strong record of continuous improvement, quality and efficiency which is essential as the NHS is facing increasing pressure.
This really is a fantastic role. If you are successful, I can promise you will enjoy your time at NHSBT as much as I enjoy my role as Chair of NHSBT.
Please visit our website at http://www.nhsbt.nhs.uk/ for more information about our organisation.
NHS Blood and Transplant Role and Responsibilities
NHS Blood and Transplant (NHSBT) is a Special Health Authority dedicated to saving and improving lives. We are an essential part of the NHS providing a wide range of services making the most of absolutely every donation – from blood and organs to tissues and stem cells.
We were formed in 2005 by bringing together the National Blood Service and UK Transplant. We are now one of the largest and most effective organisations of its type in the world.
We employ over 5,400 people across the UK, with total revenue of over £427 million, delivering blood, and blood-based therapies across England; Diagnostic and Therapeutic services globally; and organ donation and supply services for the whole of the UK.
We stand for helping ordinary people do something extraordinary, saving and improving the lives of others with their valuable donations.
To achieve this, we:
- collect and process over 1.57 million units of blood and platelets annually to ensure a constant supply of blood to hospitals from 5,500 donors giving blood every day;
- make possible some 9,300 organ and cornea transplants every year;
- retrieve and store other tissues like skin and bone ready for patient use;
- manufacture a range of specialist therapeutic blood products;
- provide a number of related services such as solid organ tissue typing and cord blood banking;
- provide apheresis services directly to patients;
- manage the NHS Organ Donor Register (which currently has nearly 25 million names) and the British Bone Marrow Registry;
- support a significant research and development programme operated in partnership with a number of the UK’s leading universities; and
- provide expert advice to other NHS organisations, the Department of Health, Ministers and devolved administrations.
In 2018/19, our donors provided:
- 1.57 million units of blood,
- 5,000 organs,
- 7,800 tissue donations, and
- 953 banked cord blood units. To find out more information about NHSBT please visit our corporate website at https://www.nhsbt.nhs.uk/
- To find out more about the journey of donors please click here to go to our website to view some helpful videos.
In performing this essential activity, we engage with millions of people throughout the country and connect directly with more people on a daily basis than any other single part of the NHS. In addition to supplying the lifesaving products that are needed by NHS patients we are immensely proud that our activities support the incredible altruism and generosity of donors and bring communities together across the country.
To find out more information about NHSBT please visit our corporate website at https://www.nhsbt.nhs.uk/
To find out more about the journey of donors please click here to go to our website to view some helpful videos.
We track our financial performance across three key areas: Blood, Organ Donation and Transplantation, and Diagnostic and Therapeutic Services.
Blood: The Directorate has continued to respond extremely well to the sustained reduction in red cell demand that has seen demand fall by a further 1.7% in 2018/19. We continue to be proud of the fact that prices for red cells in 2019/20 will be lower than they were in 2007/08, despite inflation, investing in higher safety and availability and a 23% reduction in red cell demand over that period. In aggregate the cost of red cells supplied to the NHS in 2019/20 is forecast to be circa £57m pa lower than they were in 2007/08.
Organ Donation and Transplantation: There were 1,600 deceased donors in 2018/19 (2017/18 1,574), 1.65% higher than 2017/18. However, there were only 3,953 deceased transplants in 2018/19 (2017/18 4,039), up by 2.1%. This has established a new annual record for the number of deceased donors in the UK although the number of deceased transplants has fallen for the first time.
Diagnostic and Therapeutic Services: Income in 2018/19 at £81.3m (2017/18 £75.0m) was 8.4% higher than last year. This was driven by increased activity in Therapeutic Apheresis Services (up 15%), Tissue and Eye Services (up 15%) and Red Cell Immunohaematology (up 6%).
There is a real commitment from NHSBT’s Board to ensure we are delivering on our Inclusion objectives of making NHSBT an organisation where all colleagues feel they can get on, regardless of their race, gender, sexual orientation, disability and/or other differences. Testament to this is that one of the five personal objectives for our CEO, agreed with our Board is to improve the diversity of our workforce.
A bi-annual update provided to the Board ensures all interventions are monitored and progressed and provide an opportunity to highlight areas that need more focus. Alongside this, an annual Diversity & Inclusion work plan tracks and monitors a set of workforce objectives which have been developed to ensure we progress with making NHSBT a more diverse and inclusive workplace.
As part of the backbone of the NHS, we reach the public at the most critical stages of their lives. Few organisations have the ability to reach so many, delivering the best possible service to patients, donors and the NHS. The range of our work providing diagnostic and therapeutic services, organ donation & transplantation, and blood supply, demands that our operations are world class, providing a safe, reliable and efficient supply across the UK by working seamlessly with an unparalleled range of stakeholders including government, volunteers, the health sector and academia.
Working with Millie Banerjee (Chair) and Betsy Bassis (CEO) and a highly experienced executive team to implement our expansive vision, you will have the opportunity to take us forward beyond our current Strategic Plan to make sure that we are here when people need us most. You will be excited to make your mark on such a critical organisation and will seize the opportunity to push forward our reputation for quality, ensuring existing operations remain fit for the future alongside effective collaboration with our partners.
You will be joining us at an exciting and challenging time. NHSBT has a strong record of continuous improvement, quality and efficiency which is essential as the NHS is facing increasing pressure. We have a duty to be as efficient as we possibly can so that the NHS has more resources to spend on frontline services to patients. NHSBT also has a strong record as an innovator and we aim to:
- be the supplier of choice to the NHS for tissue and eye services, stem cell therapies, therapeutic apheresis, specialist blood diagnostic (Red Cell Immunohaematology) and organ testing (Histocompatibility and Immunogenetic) services;
- increase the number of patients benefiting from curative stem cell transplants;
- develop products and innovative techniques that have the potential to deliver an income surplus that can be reinvested into services and further research; and
- lead the way on regenerative medicine.
The Role of the Board
The Board provides governance for the organisation. Its key duties are to:
- Collectively promote the success of NHS Blood and Transplant
- Provide strategic direction and set operational objectives
- Monitor the achievement of objectives through a framework of effective financial and quality management
- Set and maintain the values for the organisation and ensure that its obligation to all stakeholders, including patients, donors, the Secretary of State and Ministers in the Devolved Administrations, are understood and met.
|DHSC diversity & monitoring form (PA)|
|EXTENSION DEC 2019 - VAC-1678 NHSBT Candidate Information Pack Final|